Loading…
Monday, May 6 • 1:30pm - 2:15pm
Revolutionizing Launch Success: Redefining Metrics and Strategies

Log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
  • Explore why traditional launch success metrics may no longer suffice and discover new, more dynamic approaches to measuring and achieving launch success 
  • Highlight the critical role of medical affairs in shaping product labels, indications, and overall launch strategy from the early stages 
  • Delve into the need for early collaboration to integrate evidence generation, patient considerations, and market readiness into launch planning 
  • Understand the critical steps and considerations for initiating MSLs in the launch plan and aligning launch strategies with therapeutic goals, market dynamics, and available data. 
Moderators
avatar for Gregory Rippon, MD, MS, FAAN

Gregory Rippon, MD, MS, FAAN

Vice President & Chief Medical Partner, Neurology, Ophthalmology, & Internal Medicine, Genentech
Gregory A. Rippon, MD, MS, FAAN is Vice President and Chief Medical Partner, Neurology, Ophthalmology and Internal Medicine at Genentech. In his role, Dr. Rippon leads U.S. medical affairs portfolio and pipeline medical programs across these therapeutic areas and is a member of the... Read More →

Speakers
avatar for Suzanne Giordano, Ph.D.

Suzanne Giordano, Ph.D.

Associate Vice President, Head of Field Medical, Axsome Therapeutics
avatar for Robyn Bilmes, PharmD, BCOP.

Robyn Bilmes, PharmD, BCOP.

Senior Vice President, Global Head of Medical Affairs, Genmab
Robyn is the Senior VP, Global Head of Medical Affairs at Genmab.  Robyn joined Genmab in July 2021 as Vice President, Head of US Medical Affairs where she was responsible for building an integrated Medical Affairs organization for the US and providing strategic leadership... Read More →
avatar for Brieana Cox Buckley, PharmD, MS

Brieana Cox Buckley, PharmD, MS

Vice President, Medical Affairs and Patient Advocacy, Editas Medicine
Dr. Brieana Buckley joined Editas Medicine in May 2023 as Vice President, Medical Affairs and Patient Advocacy. She completed her PharmD from University of Utah followed by a Managed Care Residency at SelectHealth and a subsequent master’s degree in Pharmacoeconomics from the University... Read More →

Monday May 6, 2024 1:30pm - 2:15pm EDT
Newport III
  General Session
  • QTag featuredsession